drugset / Trial / NCT01930175
Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris
RandomizedParallel-groupDouble-blindTreatment
Summary
The study evaluated the efficacy, safety and pharmacokinetics of VAY736 in the treatment of patients with pemphigus vulagaris (PV).
Timeline
- Start
- 2013-12-18
- Primary completion
- 2019-09-25
- Completion
- 2019-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ianalumab | Monoclonal antibody | 3 mg/kg | Intravenous |
| Subject | Ianalumab | Monoclonal antibody | 10 mg/kg | Intravenous |